MedTrace Logo

Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial

NCT05382832 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-05-19

No results posted yet for this study

Summary

The clinical trial is focused on the treatment of selected patients with a migraine after implantation of spinal cord stimulator (SCS) based on previous neurological examination. Patients will be randomized and divided into two groups. According to randomization patients will receive saline or botox into the epidural space. The efficacy of treatment will be compared and estimated in both groups during different SCS settings. Data will be collected in pre-set time frames.

Conditions

Interventions

COMBINATION_PRODUCT

SCS

SCS-experimental treatment

COMBINATION_PRODUCT

SCS

SCS-placebo

Sponsors & Collaborators

  • National Hospital for Neurology and Neurosurgery, London

    collaborator UNKNOWN

  • Europainclinics z.ú.

    lead OTHER

Principal Investigators

  • Róbert Rapcan, MD, PhD, MBA, FIPP · EuroPainClincs

  • Ladislav Kočan, MD, PhD · EuroPainClincs

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-08-01
Completion
2025-08-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05382832 on ClinicalTrials.gov